Speaker illustration

Doctor Boglarka Veres

Semmelweis University, Budapest (Hungary)

Member of:

European Heart Rythm Association
Heart Failure Association

Boglárka Veres was born in Hungary in 1996. She acquired her medical degree in 2020 at Semmelweis University Faculty of Medicine. During her undergraduate years, she was conducting student research from 2017 to 2020 at Semmelweis University Heart and Vascular Center. Her research field focused on heart failure and cardiac resynchronization therapy. She presented her results at scientific conferences and won second place at the Semmelweis University Student’s Scientific Association’s TDK conference in 2019. Therefore she qualified to attend the National Student’s Scientific Association’s TDK conference in 2019, and she won second place. She wrote her thesis about „Machine learning defined predictors of mortality in ischemic and nonischemic heart failure patients undergoing CRTP or CRTD implantation”, and she received the first prize at Rector's Competition. In 2020 she received a scholarship and started her postgraduate studies at Semmelweis University Doctoral School.

Enhancing heart failure management: a comprehensive analysis of continuous remote monitoring vs. standard care in patients with cardiac implantable electronic devices

Event: EHRA 2024

Topic: Home and Remote Patient Monitoring

Session: ICD and remote monitoring

Thumbnail

The benefit of using remote monitoring systems compared to standard of care in heart failure patients, a systematic review and meta-analysis

Event: Heart Failure 2023

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: ePosters in arrhythmias and device therapy 2

Thumbnail

The effect of Remote Monitor vs Standard of Care therapy on outcome A systematic review and meta-analysis

Event: EHRA 2023

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Device Therapy - Brady

Thumbnail

The benefits of adding a defibrillator to cardiac resynchronization therapy - systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Outcomes in cardiac resynchronisation therapy

Thumbnail

The benefits of adding a defibrillator to cardiac resynchronization therapy - systematic review and meta-analysis

Event: Heart Failure 2022

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Unraveling epidemiology in heart failure

Thumbnail

The benefits of adding a defibrillator to cardiac resynchronization therapy - Systematic review and meta-analysis

Event: EHRA 2022

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Moderated ePosters - More on pacing

Thumbnail

Long-term outcome after adding an ICD to CRT in non-ischemic patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Device Treatment

Session: Ventricular arrhythmias and sudden cardiac death e-posters

Thumbnail

Long-term mortality benefit of adding an ICD to CRT in non-ischemic patients

Event: EHRA 2021

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: New insights into ICD therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb